Quoin Pharmaceuticals Q3 EPS $(1.95) Beats $(2.72) Estimate
Portfolio Pulse from totan@benzinga.com
Quoin Pharmaceuticals reported Q3 losses of $(1.95) per share, beating the analyst consensus estimate of $(2.72) by 28.31 percent. This represents an 82.71 percent increase over losses of $(11.28) per share from the same period last year.
November 08, 2023 | 10:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quoin Pharmaceuticals' Q3 losses were less than expected, which could be seen as a positive sign by investors.
Quoin Pharmaceuticals reported lower than expected losses for Q3, which is generally seen as a positive sign by investors. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100